Numerous studies have shown that CXCR2 ligands, such as the chemokine CXCL1, are important for neutrophil migration to tumor sites [7], and others have shown both positive and negative effects of TGF-β blockade on neutrophil migration to tumors [20, 26]. Here, TGFB1 is linked to neoplasm.